Parallel distribution provides an opportunity for Bulgarian patients to buy the same original medicines at lower prices and to have access to a variety of medicines from all EEA countries, not just those registered on the local market.
A large number of medicinal products in Bulgaria are de-registered by the first importer for non-pharmacological safety reasons. The same medicines continue to be sought by patients who, in turn, are forced to use unregulated intermediaries or their relatives to supply products from other EU Member States. Here, as a legitimate alternative, parallel import can be used.
To expand this access, there is a need of refining and amending the current legislation to make our work even more useful to patients and public funds, including to address situations of lack or shortage of medicinal products.